Physician profile
Jaye E Benjamin
NPI 1649252743
$6,525.84
in general payments reported to CMS, 2019-2025
19 companies · $448 in 2025
The $448 reported for 2025 was less than what a typical Dermatology provider received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,722 · 2020: $294 · 2021: $694 · 2022: $444 · 2023: $431 · 2024: $494 · 2025: $448.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,373.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,372.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $3,745.98 | 2019-2025 | |
| Abbvie INC. | $399.54 | 2019-2025 | Skyrizi |
| Lilly USA, LLC | $345.90 | 2019-2025 | Taltz, Ebglyss, Olumiant |
| Janssen Biotech, INC. | $310.97 | 2020-2025 | Tremfya, Simponi, Simponi Aria |
| Novartis Pharmaceuticals Corporation | $265.10 | 2019-2025 | |
| Ucb, INC. | $249.62 | 2021-2025 | Bimzelx, Cimzia |
| Genzyme Corporation | $239.36 | 2021-2025 | |
| Amgen INC. | $186.87 | 2020-2025 | Otezla, Otezla |
| Galderma Laboratories, L.P. | $152.98 | 2019-2022 | |
| Dermavant Sciences, INC. | $120.80 | 2023-2024 | Vtama |
| Sun Pharmaceutical Industries INC. | $108.52 | 2020-2021 | |
| Sanofi-Aventis U.S. LLC | $94.49 | 2021 | |
| Regeneron Healthcare Solutions, INC. | $89.17 | 2021-2025 | Libtayo |
| E.R. Squibb & Sons, L.L.C. | $55.42 | 2022-2024 | Sotyktu |
| Almirall LLC | $41.51 | 2022 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Leo Pharma INC. | $40.73 | 2020-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $37.08 | 2023 | Spevigo, Cyltezo |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $23.67 | 2019-2021 | |
| Incyte Corporation | $18.13 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jaye Benjamin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.